Lv3
240 积分 2024-02-20 加入
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
8天前
已完结
Rectal Cancer Update: Which Treatment Effects Are the Least “Brutal”?
1个月前
已完结
Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options
1个月前
已完结
Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
1个月前
已完结
Primary Surgery Followed by Selective Chemoradiotherapy Versus Preoperative Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer: A Randomized Clinical Trial
2个月前
已完结
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
3个月前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
4个月前
已关闭
Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial
4个月前
已完结
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features
5个月前
已完结
皖公网安备34019202002308
